Stroke remains a leading cause of morbidity and is the second leading cause of death globally 1 despite advances in treatment and prevention over the past decade. In this issue of Neurology ® , Kelly et al. 2 use administrative data on acute stroke hospitalizations among adults aged 18 years or older in Germany between 2014 and 2019 to describe updated trends in stroke admissions, treatment modalities, and mortality nationally. Using population-level data from the Federal Statistics Office in Germany, study authors calculated frequencies of hospitalizations for acute stroke over a 6-year period. Study authors then evaluated demographic and clinical characteristics of stroke cases and evaluated trends in the utilization of interventions such as carotid stenting, systemic thrombolysis, and thrombectomy. They also calculated proportions of stroke cases in which in-hospital death occurred, followed by logistic regression models to investigate predictors of in-hospital mortality.Across all study years, more than 1.8 million hospitalizations for acute stroke were included; total stroke and ischemic stroke hospitalizations were stable over time (377.38 per 100,000 population in 2014 to 375.98 in 2019 for total stroke and 314.39 to 317.75 per 100,000 population for ischemic stroke), and there was a slight decrease in hemorrhagic strokes between 2014 and 2019 (62.99-58.23 per 100,000 population, respectively). It is of importance that these data add to our current knowledge of temporal trends in stroke over time and provide data through 2019, an update from past US-based studies. [3][4][5] The results of this study conflict to some extent, however, with studies that have demonstrated decreases in stroke incidence over time. [3][4][5][6] Findings from the study conducted by Kelly et al. 2 also differ from previous US-based studies, indicating that stroke in younger adults is increasing or stable, 3,7 while stroke in middle and older-age adults is decreasing. 3,4,8 A strength of the study by Kelly et al. compared with that of other cohort and population-based studies of stroke incidence over time include an updated time frame (through 2019) and use of national-level data, but this study 2 did not report age-standardized rates, preventing direct comparisons with other study populations. The use of administrative data rather than physician-adjudicated strokes may also introduce some limitations. In addition, previous studies of temporal trends in stroke incidence over time have used a stable definition of stroke, independent of changes in imaging utilization. 3 Specifically, increased use of MRI over time could have affected the findings of Kelly et al. 2 Finally, this study does not report the race and ethnicity of patients or data on social determinants of health, though disparities in access to care may be less of a contributor to stroke outcomes in Germany, a country with universal health care. Despite these limitations, in addition to being a large population-based investigation across an entire country, an important str...